Semler Scientific (SMLR) Misses Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Semler Reports First Quarter 2022 Financial Results
May 2, 2022 4:01 PM EDT2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021:
Revenues were $14.0 million, an increase of $0.8 million, or 6%, compared to $13.2 millionNet income was $3.4 million, or $0.50 per basic share and $0.41 per diluted share, compared to $4.9 million, or $0.73 per basic share and $0.60 per diluted shareCash at March 31, 2022 increased to $38.4 million from $26.5 millionSANTA CLARA, Calif., May 2, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and... More
